Eli Lilly has filled its plate with potential obesity treatments, unveiling data from two more on Monday. One offers the convenience of a pill; the other, with the scientific name retatrutide, led to patients losing an astonishing 24% of their weight at the highest dose.
, but is this just more pharmaceutical R&D overkill? Perhaps, but there are justifiable reasons for it.
While doctors are reluctant to switch patients from working therapies, theoretically giving an advantage to first movers, drugs vary in effectiveness, side effects and convenience. Pfizer’s cholesterol-lowering Lipitor, for one, reached consumers after rivals, and a decade after Merck’s version. Yet its higher ability in reducing cholesterol, along with aggressive marketing, made Lipitor the best-selling drug worldwide for years, with total revenue topping $150 billion.
Lilly’s research budget, projected at 24% of revenue this year, exceeds that of many peers, including Pfizer’s
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Eli Lilly Experimental Obesity Drug Could Beat Rivals in Total Weight Loss for PatientsObese or overweight patients who took Eli Lilly’s retatrutide lost 58 pounds on average, the pharmaceutical company said in a mid-stage clinical trial.
Baca lebih lajut »
Next-generation drug from Eli Lilly boosts weight loss to 24%, highest yet seen in trialsIn addition to the 24% average weight loss on the highest dose in the trial – about 58 pounds over 11 months – a quarter of patients on that dose experienced weight loss of at least 30%.
Baca lebih lajut »
Daily pill from Eli Lilly leads to 15% weight loss in midstage study, rivaling Wegovy results without the shotEli Lilly’s experimental pill for weight loss helped people lose an average of 15% of their body weight after 36 weeks on the highest dose in a midstage trial.
Baca lebih lajut »
Experimental drug could offer more weight loss than any drug now on the market, study findsThe experimental drug, retatrutide, helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds, in a mid-stage clinical trial, the company says.
Baca lebih lajut »
Woman in clinical trial for new weight loss drug lost 60 pounds in less than a yearThe new findings, according to Dr. Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, are “mind-blowing.”
Baca lebih lajut »
Eli Manning, Fanatics donate $20 million worth of merchandise to support families in needFanatics teamed up with sports personalities including Eli Manning to donate over 300,000 pieces of apparel worth about $20 million to assist 100,000 families in need.
Baca lebih lajut »